Express Healthcare
Home  »  News  »  Quadria Capital successfully closes its latest fund, Quadria Capital Fund II

Quadria Capital successfully closes its latest fund, Quadria Capital Fund II

0 21
Read Article

Increasing hard cap far exceeding its $400 million target

Quadria Capital recently announced that it has successfully closed its latest fund, Quadria Capital Fund II, at its increased hard cap far exceeding its $400 million target. Investors include leading global asset managers, pension funds, sovereign wealth funds, insurance, healthcare corporates and development finance institutions across the US, Europe and Asia.

Abrar Mir, Managing Partner, Quadria Capital, said, “We are extremely excited about the successful close of our second fund as we build on our consistent strategy to capture the region’s immense healthcare opportunity. Asia’s healthcare market is expected to reach $4.2 trillion in the next five years, exceeding that of the US and Europe combined today. It will continue to grow at 12 per cent annually, compared to 5 per cent growth globally.”

Quadria Capital Fund II has already made two milestone investments in AKUMS Drugs & Pharmaceuticals and the Asian Institute of Gastroenterology in partnership with the Mayo Clinic Network.

“We are pleased to be supported by like-minded global investors to deliver sustainable impact beyond compelling financial returns. As a strategic partner to the healthcare businesses that we invest in, we bring to bear Quadria’s proprietary healthcare ecosystem of healthcare professionals, companies, technologies and expertise to support long-term growth and value creation,” added Mir.

“Countries in South and South-east Asia are home to nearly a third of the world’s population and shoulder almost half of the world’s diseases burden. However, they receive just 5 per cent of the global expenditure, and this severe underfunding of public health expenditure is challenging their development. This compounds the other issues faced by these regions including demographic changes such as fast-growing and ageing populations, exposure to chronic diseases as well as increased exposure to infectious diseases – including Covid-19 – that have been spreading exponentially recently,” said Dr Amit Varma, Managing Partner, Quadria Capital.

Leave A Reply

Your email address will not be published.

Webinar on COVID 19 Response Plan: Key lessons from the HIV epidemic
Register Now